ARCHIVES

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 21 No. 33 | August 18, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Offers Chlorozotocin

November 18, 1977

Heart Institute Withdraws Sponsorship Of Breast Cancer Prevention Trial

October 27, 1995

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995

NCAB Committee Approves Staff Plan For New Comprehensive Cancer Center Grant Mechanism

April 29, 1988